NCT06463353View on ClinicalTrials.gov

Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.

NANot yet recruitingINTERVENTIONAL

Enrollment

376

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

November 30, 2027

Conditions

Atopic Dermatitis

Interventions

OTHER

trilinolein cream group

Apply trilinolein cream evenly to the affected skin twice daily. The dosage is calculated using Finger Tip Units (FTU) and should not exceed a maximum of 30 grams per day.

OTHER

cream base group

Apply cream base evenly to the affected skin twice daily. The dosage is calculated using Finger Tip Units (FTU) and should not exceed a maximum of 30 grams per day.

All Listed Sponsors

lead

Shanghai Yueyang Integrated Medicine Hospital

OTHER

NCT06463353 - Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis. | Biotech Hunter | Biotech Hunter